Find a Health Care Professional / Researcher

Amal H. Assa'ad, MD

Title

Director, Fellowship Training Program; Director, Clinical Services

Appointment

Professor of Pediatrics, Allergy/Immunology, University of Cincinnati College of Medicine

Email

Amal.Assa'ad@cchmc.org

Phone

513-636-6771

Fax

513-636-4615

Credentials

MBBCh (MD): Ain Shams University, Cairo, Egypt 1978.

MS: Ain Shams University, Cairo, Egypt, 1982.

Residency: Internal Medicine/Pediatrics, Michigan State University, Hurley Medical Center, Flint, Mich.; Internal Medicine/Pediatrics, Wright State University, Dayton, Ohio, 1990-1992.

Fellowship: Allergy/Clinical Immunology, University of Texas Health Science Center, San Antonio, Texas, 1986-1987; Allergy/Clinical Immunology, Children's Hospital Medical Center, Cincinnati, Ohio, 1992-1995.

Certification: American Board of Internal Medicine, 1992; American Board of Pediatrics, 1992; American Board of Allergy and Immunology, 1995.

Awards and Honors

Best Doctors in America, 2008
Awarded "2005 Best Doctors"
Awarded "2004 Best Doctors"

Publications, Most Recent

Sutton S.; Assa'ad A.H.; Rothenberg M.E. Anti-IL-5 and Hypereosinophilic Syndromes.Clinical Immunology 2005; 115:51-60

Assa'ad, A.H., Detection of causative foods by skin prick and atopy patch tests in patients with eosinophilic esophagitis: things are not what they seem, Ann Allergy Asthma Immunol 2005; 95 (4) 309-11

Blanchard, C.; Wang, N.; Stringer, K. F.; Mishra, A.; Fulkerson, P.C.; Abonia, J.P.; Jameson, S.C.; Kirby, C.; Konikoff, M.R.; Collins, M.H.; Cohen, M.B.; Akers, R.; Hogan, S.P.; Assa'ad, A.H.; Putnam, P.E.; Aronow, B.J.; Rothenberg, M.E. Eotaxin-3/CCL26 and a uniquely conserved gene-expression profile in eosinophilic esophagitis, J Clin Ivestigator, 2006; 116(2):536-47

Assa'ad, A.H.. Gastrointestinal food allergy and intolerance.Pediatr Ann 2006; 35(10): 718-26

Fiocchi, A.; Assa'ad, A.H.; S. Bahna. "Food allergy and the introduction of solid foods to infants: a consensus document. Adverse Reactions to Foods Committee, American College of Allergy, Asthma and Immunology."Ann Allergy Asthma Immunol 2006; 97(1): 10-20; quiz 21, 77.

Konikoff, M.R.; Noel, R.J.; Blanchard, C.; Kirby, C.; Jameson, S.C.; Buckmeier, B.K.; Akers, R.; Cohen, M.B.; Collins, M.H.; Assa'ad, A.H.; Aceves, S.S.; Putnam, P.E.; Rothenberg, M.E. "A Randomized, Double-Blind, Placebo-Controlled Trial of Fluticasone Propionate for Pediatric Eosinophilic Esophagitis."Gastroenterology, 2006;131(5): 1381-91.

Stein, M.L.; Collins, M. H.; Villanueva, J.M.; Kushner, J.P.; Putnam, P.E.; Buckmeier, B.K.; Filipovich, A.H.; Assa'ad, A.H.; Rothenberg, M.E. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis.J Allergy Clin Immunol 2006; 118(6): 1312-9

Assa’ad A.H.; Putnam E.D.; Collins M.H.; Akers R.; Jameson S.; Konikoff M.; Noel R.; Guajardo J.R.; Rothenberg M.E. Pediatric patients with eosinophilic esophagitis: An eight-year follow up J Allergy Clin Immunol 2007; 119(3):731-8

Bullock J.Z.; Villanueva J.M.; Blanchard C.; Filipovich A.H.; Putnam P.E.; Collins M.H.; Risma K.A.; Akers R.M.; Kirby C.L.; Buckmeier B.K.; Assa'ad A.H.; Hogan S.P.; Rothenberg M.E. "Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis."J Pediatr Gastroenterol Nutr 2007; 45(1): 22-31.

Assa'ad, A., Eosinophilic esophagitis: association with allergic disorders. Gastrointest Endosc Clin N Am, 2008. 18(1): p. 119-32; x.

Gupta, J.; Gupta, J.; Grube, E.; Ericksen, M.B.; Stevenson, M.D.; Lucky, A.W.; Sheth, A.P.; Assa'ad, A.H.; Khurana Hershey, G.K. Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. J Allergy Clin Immunol, 2008. 121(3): 725-730 e2.

Stein, M.L.; Villanueva, J.M.; Buckmeier, B.K.; Yamada, Y.; Filipovich, A.H.; Assa'ad, A.H.; Rothenberg, M.E., Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels. J Allergy Clin Immunol, 2008. 121(6): 1473-83, 1483 e1-4.

Collins M.H.; Blanchard C.; Abonia J.P.; Kirby C.; Akers R.; Wang N.; Putnam P.E.; Jameson S.C.; Assa'ad A.H.; Konikoff M.R.; Stringer K.F.; Rothenberg M.E. Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases. Clin Gastroenterol Hepatol. 2008;6(6):621-629.

Assa’ad A.H.; Gastrointestinal Eosinophil-Mediated Disorders and their Treatment.Current Allergy and Asthma Reports, 2009. 9(1): 26-9

Assa'ad A. Eosinophilic gastrointestinal disorders. Allergy Asthma Proc. 2009;30(1):17-22.

Metz K.A.; Johnson T.; Hershey G.K.; Lierl M.B.; Seidu L.; Burns K.; Assa'ad A. Successful administration of cytarabine in a 16-month-old girl with acute myelogenous leukemia and cytarabine syndrome. Ann Allergy Asthma Immunol. 2009 Feb;102(2):173-4.